Skip to main content
  • Immunotherapy
    in Actions
    The new wave of immunotherapy antibodies in cancers and rare haematological diseases
  • ElsaLys Biotech
    A clinical stage immuno-oncology company that designs and develops
    a new generation of therapeutic antibodies

Welcome to ElsaLys Biotech

ELSALYS BIOTECH is a pharmaceutical company which develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases.
Its mission is at the heart of personalised and precision medicine where the ultimate goal is to increase the proportion of responders to new treatments.

Today ELSALYS BIOTECH is conducting 5 proprietary development programs including LEUKOTAC®, an immunotherapy antibody that has recently demonstrated its clinical superiority in Phase 3 in an orphan disease with very poor prognosis: steroid-resistant acute Graft-versus-Host Disease.

The company is acting today in 3 main medical fields :

"LEUKOTAC® has a role to play in the management of steroid-resistant acute graft-versus-host disease (SR-aGvHD) with a considerable decrease of mortality in these patients.

LEUKOTAC® will be used in SR-aGvHD with no doubt, because of our huge experience of this drug. Once it is available again, it will be administrated and we can think about its potential use in the first line of treatment"

Pr. Mauricette Michallet

Previously Head of Haematology Unit Lyon Civil Hospices, Today in charge of post cancer at the Centre Léon Bérard

New Updates

Discover our latest news regarding our pipeline, our partnerships and more

Fri, 04/20/2018 - 08:30

Not to be distributed directly or indirectly in the United States, Canada, Australia or Japan

 

Thu, 04/05/2018 - 09:00
  • ELSALYS BIOTECH plans to submit to the European Medicines Agency before summer 2018 a Paediatric Investigation Plan (PIP) proposing to c

Thu, 03/15/2018 - 17:00
  • A poster summarising the safety profile results of the randomised Phase 3 testing LEUKOTAC® in patients with steroid-resistant acute gra

STAY IN TOUCH WITH OUR LATEST NEWS

Subcribe to our newsletter